HER2 Gene Mutation Active Not Recruiting Phase 2 Trials for Trastuzumab (DB00072)

IndicationStatusPhase
DBCOND0081068 (HER2 Gene Mutation)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT06083662Neratinib and Trastuzumab Biosimilar in Patients With HER2 Mutated Advanced Solid CancersTreatment